Johnson & Johnson (NYSE:JNJ)
$ 259.33 -3.71 (-1.41%) Market Cap: 624.26 Bil Enterprise Value: 657.20 Bil PE Ratio: 29.98 PB Ratio: 7.69 GF Score: 81/100

Johnson & Johnson at JPMorgan Healthcare Conference Transcript

Jan 12, 2026 / 04:15PM GMT
Release Date Price: $209.72 (+2.61%)
Christopher Schott
JPMorgan Chase & Co - Analyst

Good morning. I'm Chris Schott from J.P. Morgan. And it's my pleasure to be hosting this fireside discussion with Joaquin Duato, the Chairman and CEO of J&J. Joaquin, happy new year.

Questions & Answers

Joaquin Duato
Johnson & Johnson - Chairman of the Board, Chief Executive Officer

Thank you.

Christopher Schott
JPMorgan Chase & Co - Analyst

Great speaking with you today. Can we just open up the conversation? We're coming off of a year with significant outperformance for the stock, some really impressive underlying fundamentals. We'd love just to hear about your top priorities for the company as we enter 2026.

Joaquin Duato
Johnson & Johnson - Chairman of the Board, Chief Executive Officer

Thank you. So first, thank you for organizing this impressive meeting. Every year, J.P. Morgan does a very good job in bringing us all together and kicking off the year. So thank you for doing that. And

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot